N. Scott Fine, Chief Executive Officer at Cyclo Therapeutics, Inc. (CYTH), bought 598,804 shares at $0.71 ($425K) on 2023-04-20, disclosed to the SEC on 2023-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 299,402 | $213K | 50.0% |
| 2 | $0.71 | 299,402 | $213K | 50.0% |
| Total | $0.71 avg | 598,804 | $425K | 100% |
| Filing → |
| CYTH | BUY | 2021-12-15 | $19K | — | Filing → |
| CYTH | BUY | 2021-12-02 | $25K | — | Filing → |
| CYTH | BUY | 2021-11-19 | $26K | — | Filing → |